MME
QGENF

Meag Munich Ergo’s QIAGEN NV QGENF Stock Holding History

Meag Munich Ergo’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-127,000
Closed -$3.6M – 373
2016
Q4 		$3.6M Sell
127,000
-50,000
-28% -$1.42M 0.17% 157
2016
Q3 		$4.77M Hold
177,000
– – 0.23% 120
2016
Q2 		$3.83M Sell
177,000
-75,813
-30% -$1.64M 0.35% 86
2016
Q1 		$5.63M Buy
252,813
+21,213
+9% +$472K 0.29% 109
2015
Q4 		$6.36M Sell
231,600
-35,000
-13% -$961K 0.32% 98
2015
Q3 		$6.31M Buy
266,600
+3,600
+1% +$85.2K 0.34% 94
2015
Q2 		$6.48M Sell
263,000
-104,000
-28% -$2.56M 0.33% 96
2015
Q1 		$9.26M Buy
367,000
+20,000
+6% +$505K 0.44% 78
2014
Q4 		$8.19M Buy
347,000
+74,000
+27% +$1.75M 0.37% 96
2014
Q3 		$6.23M Hold
273,000
– – 0.29% 113
2014
Q2 		$6.63M Hold
273,000
– – 0.29% 106
2014
Q1 		$5.72M Sell
273,000
-22,629
-8% -$474K 0.42% 81
2013
Q4 		$6.91M Buy
+295,629
New +$6.91M 0.41% 89

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Meag Munich Ergo's QGENF Position: Q1 2017 in Review

Meag Munich Ergo sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 127,000 shares — an estimated $3.6M sold.

Meag Munich Ergo first reported a position in QGENF in Q4 2013 and held it in 13 quarters. The position peaked at $9.26M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Meag Munich Ergo reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Meag Munich Ergo sold 127,000 QIAGEN NV shares in Q1 2017, an estimated $3.6M.
  • Meag Munich Ergo first reported a position in QIAGEN NV in Q4 2013 and held it in 13 quarters.
  • Meag Munich Ergo's QIAGEN NV position peaked at $9.26M in Q1 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Meag Munich Ergo's 13F filing for Q1 2017, filed 10 May 2017.